Format

Send to

Choose Destination
Microbiol Immunol. 2016 Dec;60(12):854-858. doi: 10.1111/1348-0421.12456.

Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014.

Author information

1
Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031.
2
Yamanobe Pediatric Clinic, Yamanobe, Yamagata, 990-0301.
3
Department of Infectious Diseases, Yamagata University Faculty of Medicine, Iida-Nishi, Yamagata, 990-9585, Japan.

Abstract

To clarify the seroepidemiology of human parechovirus type 1 (HPeV1), 3 and 6, neutralizing antibodies (NT Abs) were measured in 214 serum specimens collected in 2014 in Yamagata, Japan. The seroprevalence against HPeV1 was 100% in all age groups, while that against HPeV3 and HPeV6 was 79.4% and 66.8%, respectively, overall. The geometric mean titers of NT Abs against HPeV1, 3 and 6 were 755.2, 255.0 and 55.9, respectively, overall. Our findings indicate that HPeV1 is the most prevalent HPeV circulating in Yamagata, followed by HPeV3 and HPeV6.

KEYWORDS:

emerging disease; human parechovirus; seroepidemiology

PMID:
27925289
DOI:
10.1111/1348-0421.12456
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center